A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...
PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj. ® Multi-dose is manufactured ...
A novel vaccine designed to combat both typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has shown promising results in an initial human trial, raising hopes for better protection ...
Typhoid fever, an illness that has been controlled in developed countries since the early 20th century, is evolving to be antibiotic-resistant. Research published in 2022 shows that typhoid is ...
Hosted on MSN
Travel smart with typhoid prevention tips
Why it matters: Typhoid can cause prolonged illness and even death if untreated, with most U.S. cases linked to international travel. Who’s at risk: Travelers to South Asia, Africa, and Latin America ...
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results